Frailty in community-dwelling older people: comparing screening instruments by Carneiro, Jair Almeida et al.
1https://doi.org/10.11606/s1518-8787.2020054002114
Original ArticleRev Saude Publica. 2020;54:119
Frailty in community-dwelling older 
people: comparing screening instruments
Jair Almeida CarneiroI , Andressa Samantha Oliveira SouzaII ,Luciana Colares MaiaIII , 
Fernanda Marques da CostaIV , Edgar Nunes de MoraesV , Antônio Prates CaldeiraVI
I Universidade Estadual de Montes Claros. Centro de Ciências Biológicas e da Saúde. Departamento de Saúde 
Mental e Saúde Coletiva. Montes Claros, MG, Brasil
II Universidade Estadual de Montes Claros. Centro de Ciências Biológicas e da Saúde. Montes Claros, MG, Brasil
III Universidade Estadual de Montes Claros. Centro de Ciências Biológicas e da Saúde. Departamento de Clínica 
Médica. Montes Claros, MG, Brasil
IV Universidade Estadual de Montes Claros. Centro de Ciências Biológicas e da Saúde. Departamento de 
Enfermagem. Montes Claros, MG, Brasil
V Universidade Federal de Minas Gerais. Faculdade de Medicina. Departamento de Clínica Médica. Belo 
Horizonte, MG, Brasil
VI Universidade Estadual de Montes Claros. Centro de Ciências Biológicas e da Saúde. Departamento de Saúde 
da Mulher e da Criança. Montes Claros, MG, Brasil
ABSTRACT
OBJECTIVE: To compare the Edmonton Frail Scale (EFS) and Clinical-Functional Vulnerability 
Index-20 (CFVI-20) instruments regarding degree of agreement and correlation and compare 
descriptive models with frailty-associated variables in community-dwelling older people in Brazil.
METHODS: Cross-sectional study, nested in a population-based and household cohort. 
Baseline sampling was calculated based on a probabilistic approach by conglomerate in two 
stages. In the first stage, census tract was used as sampling unit. In the second, the number of 
households was defined according to the population density of individuals aged ≥ 60 years. The 
Kappa statistic evaluated the agreement between instruments and Pearson’s coefficient their 
correlation. Factors associated with frailty and high risk of clinical-functional vulnerability 
were identified by multiple analysis of Poisson regression with robust variance.
RESULTS: Kappa statistics was 0.599 and Pearson’s correlation coefficient 0.755 (p < 0.001). 
The EFS found a 28.2% prevalence of frailty, and the CFVI-20 found a 19.5% prevalence of high 
risk of clinical-functional vulnerability. Age equal to or greater than 80 years, history of stroke, 
polypharmacy, negative self-perceived health, fall in the past 12 months, and hospitalization in 
the past 12 months were variables associated with frailty in both instruments after multiple 
analysis. Less than four years of education, osteoarticular disease, and weight loss were 
associated with frailty only by EFS, and having a caregiver was associated with a high risk of 
clinical-functional vulnerability only by CFVI-20.
CONCLUSIONS: Although the analyses show moderate agreement and strong positive 
correlation between the instruments, the indicated prevalence of frailty is discrepant. Our 
results attest the need to standardize the instrument for assessing frailty in community-
dwelling older people.
DESCRIPTORS: Aged. Frailty, Epidemiology. Reproducibility of Results. Risk Factors. Health 
Surveys, Instrumentation.
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INTRODUCTION
By entailing a complex interaction of biological, psychological, and social factors, frailty 
in older people is a clinically recognizable multidimensional syndrome resulting from a 
decrease in energy reserves and age-related changes1–3. It often affects older adults with 
disproportionate health condition changes after stressful events, causing adverse clinical 
outcomes, such as impairment in activities of daily living, physical limitation, falls, 
hospitalization, and even death2,4–6.
The prevalence of frailty is expected to increase considerably with the population dynamics 
expected for the coming years2,4. Identifying frail older adults or those at-risk of frailty is 
a public health priority. Further appropriate interventions are required to reverse this 
condition severity or, for those whose condition is irreversible, reduce adverse outcomes7.
The Comprehensive Geriatric Assessment is the most appropriate strategy to identify and 
classify frail older adults3,4,8. It enables the identification of conditions that compromise 
patients’ health for developing a management plan addressing these conditions4,9. However, 
this specialized assessment method is considered complex and costly, especially when 
applied without distinction in community-dwelling older people3,8,9.
Although challenging, finding different ways of identifying frailty in community context is 
necessary due to the high cost incurred by older adults’ care in inappropriate places. Patients 
must be referred for the appropriate place for care, according to their needs. Several simple, 
fast-tracking instruments were developed5,10,11, but selecting from among them is difficult 
due to the lack of standard measure for frailty5. Besides that, the reliability and validity of 
most of them were not assessed5,10.
Among instruments following the best practices for complex measures development, we 
may stress the Edmonton Frail Scale (EFS)10 – an easy handling and simple application 
clinical proposal, even for professionals not specialized in geriatrics or gerontology12,13. 
Recently, the Clinical-Functional Vulnerability Index-20 (CFVI-20) was also developed in 
Brazil. Despite presenting a high degree of validity and reliability14, it is still little employed 
by researchers and health professionals.
EFS and CFVI-20 were not yet simultaneously employed in the same community-dwelling 
older population, and few studies compared these instruments with others serving the 
same purpose15–20. Comparing two tests allow us to investigate evidence of convergent 
validity; that is, the degree of agreement between the measured constructs. Given that both 
instruments assess the same construct and were validated by the Comprehensive Geriatric 
Assessment, we could expect a high degree of correlation. This study aims to compare EFS 
and CFVI-20 regarding the degree of agreement and correlation and compare descriptive 
models with frailty-associated variables in community-dwelling older people in Brazil.
METHODS
This is a cross-sectional study nested with a population-based cohort and conducted with 
community-dwelling older people from the municipality of Montes Claros, in the north of 
Minas Gerais, Brazil. The municipality has approximately 400,000 inhabitants and is the 
main urban hub within the region.
Baseline sampling was calculated between May and July 2013 based on a probabilistic 
approach by conglomerate, in two stages. In the first stage, census tract was used as sampling 
unit. In the second, the number of households was defined according to the population 
density of individuals aged ≥ 60 years.
Our research data refer to the study first wave and were collected between November 2016 and 
February 2017. At this stage, the residence of all older adults interviewed at baseline was 
3
Comparing frailty instruments Carneiro JA et al.
https://doi.org/10.11606/s1518-8787.2020054002114
considered eligible for the new interview. As oriented by data collection instruments, older 
adults unable to answer the questionnaire were supported by family members or caregivers12-14.
EFS assesses nine domains (cognition, general health status, functional independence, social 
support, medication, nutrition, mood, urinary incontinence, and functional performance) 
distributed into 11 items with scores ranging from 0 to 17. Final score from 0 to 4 indicates 
no frailty; 5 and 6 indicate vulnerability to frailty; 7 and 8 mild frailty; 9 and 10, moderate 
frailty; and 11 or more indicate severe frailty12,13.
The CFVI-20 is a multidimensional assessment instrument containing 20 items that 
cover eight predictors of clinical-functional decline in older adults (age, self-perceived 
health, functional disabilities, cognition, mood, mobility, communication, and multiple 
comorbidities)14. Its score ranges from 0 to 40. Final score from 0 to 6 points indicates low 
risk of clinical-functional vulnerability; from 7 to 14 moderate risk; and 15 or higher indicate 
high risk, potentially frail21.
Dependent variables results were dichotomized at two levels: no frailty (final score ≤ 6) and 
frailty (final score > 6) according to the EFS; and no frailty (final score < 15) and frailty (final 
score ≥ 15) according to the CFVI-20. Independent variables were also dichotomized: gender, 
age group (up to 79 years or ≥ 80 years), marital status (with or without a partner), family 
arrangement (living alone or accompanied), education level (up to or more than four years 
of education), literacy (can read or not), own income (yes or no), household monthly income 
(up to or more than one minimum wage), self-reported chronic morbidities (hypertension, 
diabetes mellitus, heart disease, osteoarticular disease, neoplasia, stroke), polypharmacy (yes 
or no) and self-perceived health – assessed by the question “How would you rate your health 
status?”, with the following response options: “very good,” “good,” “fair,” “poor” or “very poor”.
Positive self-perceived health was classified as “very good” and “good” responses, while “fair,” 
“poor,” and “very poor” were classified as negative22,23. Self-reported weight loss in the past 
three months (yes or no), presence of caregiver (yes or no), fall in the past 12 months (yes 
or no), and hospitalization in the past 12 months (yes or no) were also evaluated.
Bivariate analyses were performed in both scales using the chi-square test to identify factors 
associated with response variable. Poisson regression with robust variance was used to 
calculate adjusted prevalence ratios (PR), considering independent variables associated 
with frailty in the bivariate analysis up to 20% significance level (p< 0.20). Analyses were 
performed separately for each instrument.
Considering frailty dichotomization (fragile × non-fragile), kappa statistics were applied to 
verify the agreement between EFS and CFVI-20 and interpreted according to Landis and 
Koch24. Instruments correlation was assessed based on the total scores, using Pearson’s 
coefficient25. A significance level of 5% (p < 0.05) was set for all analyses. Collected data were 
analyzed using the Statistical Package for the Social Sciences (SPSS) version 17.0 (SPSS for 
Windows, Chicago, USA).
All participants were provided with information on the research and agreed to participate 
by signing an informed consent form. The project was approved by the Research Ethics 
Committee of the Faculdades Integradas Pitágoras de Montes Claros under the Opinion 
No. 1,629,395.
RESULTS
Among the 685 older adults evaluated at baseline, 92 refused to participate in the second 
stage of the study, 78 changed residence and could not be located, 67 were not found at home 
after three visits, and 54 had died. Then, 394 community-dwelling older adults participated 
in the study. The most predominant age group was between 60 and 79 years, representing 
76.6% of the sample, with mean age of 73.9 years (SD = 7.9).
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Table 1. Demographic, social, economic, and morbidity characterization, health-related care, and frailty-associated factors in community-dwellers 
older adults (bivariate analysis), 2017.
Independent variables
Sample Frailty in the Edmonton Frail Scale (n = 394)
Frailty in the Clinical-Functional 






n % n % n % n %
Gender 0.982 0.871
Male 131 33.2 37 28.2 94 71.8 25 19.1 106 80.9
Female 263 66.8 74 28.1 189 71.9 52 19.8 211 80.2
Age group < 0.001 < 0.001
Up to 79 years 302 76.6 70 23.2 232 77.8 35 11.6 267 88.4
≥ 80 years 92 23.4 41 44.6 51 55.4 42 45.7 50 54.3
Marital status 0.378 0.039
With partner 195 49.5 51 26.2 144 73.8 30 15.4 165 84.6
Without partner 199 50.6 60 30.2 139 69.8 47 23.6 152 76.4
Family arrangement 0.977 0.218
Living alone 50 12.7 14 28.0 36 72.0 13 26.0 37 74.0
Living accompanied 344 87.3 97 28.2 247 71.8 64 18.6 280 81.4
Education level < 0.001 0.002
Up to 4 years 295 74.9 100 33.9 195 66.1 68 23.1 227 76.9
> 4 years 99 25.1 11 11.1 88 88.9 9 9.1 90 90.9
Literacy 0.001 0.023
Yes 300 76.1 72 24.0 228 76.0 51 17.0 249 83.0
No 94 23.9 39 41.5 55 58.5 26 27.7 68 72.3
Own income 0.263 0.123
No 39 9.9 8 20.5 31 79.5 4 10.3 35 89.7
Yes 355 90.1 103 29.0 252 71.0 73 20.6 282 79.4
Household monthly income 0.109 0.040
Up to one minimum wage 102 25.9 35 34.3 67 65.7 27 26.5 75 73.5
> one minimum wage 292 74.1 76 26.0 216 74.0 50 17.1 242 82.9
Hypertension 0.029 0.047
Yes 281 71.3 88 31.3 193 68.7 62 22.1 219 77.9
No 113 28.7 23 20.4 90 79.6 15 13.3 98 86.7
Diabetes mellitus 0.215 0.631
Yes 90 22.8 30 33.3 60 66.7 16 17.8 74 82.2
No 304 77.2 81 26.6 223 73.4 61 20.1 243 79.9
Heart disease 0.003 < 0.001
Yes 110 27.9 43 39.1 67 60.9 35 31.8 75 68.2
No 284 72.1 68 23.9 216 76.1 42 14.8 242 85.2
Osteoarticular disease 0.002 0.040
Yes 189 48.0 67 35.4 122 64.6 45 23.8 144 76.2
No 205 52.0 44 21.5 161 78.5 32 15.6 173 84.4
Neoplasia 0.045 0.001
Yes 38 9.6 16 42.1 22 57.9 15 39.5 23 60.5
No 356 90.4 95 26.7 261 73.3 62 17.4 294 82.6
Cerebrovascular accident 0.001 < 0.001
Yes 29 7.4 16 55.2 13 44.8 13 44.8 16 55.2
No 365 92.6 95 26.0 270 74.0 64 17.5 301 82.5
Polypharmacy < 0.001 < 0.001
Yes 107 27.2 53 49.5 54 50.5 35 32.7 72 67.3
No 287 72.8 58 20.2 229 79.8 42 14.6 245 85.4
Self-perceived health < 0.001 < 0.001
Negative 207 52.5 90 43.5 117 56.5 62 30.0 145 70.0
Positive 187 47.5 21 11.2 166 88.8 15 8.0 172 92.0
(Continue)
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In total, 66.8% were female, 50.6% lived alone, and 74.9% had up to four years of education; 
88.3% did not have a caregiver, 71.3% had hypertension, and 48% had osteoarticular diseases. 
Table 1 shows sample characteristics and bivariate analyses results.
Table 2. Frequency of Edmonton Frail Scale components in community-dwellers older adults, 2017.




Rejected with minor mistakes 64 16.2
Rejected with major mistakes 252 64.0
General health status
(hospitalization in the past 12 months)
None 337 85.5
1 to 2 48 12.2
More than 2 9 2.3
Self-perceived health
Excellent/very good/good 187 47.5
Poor 180 45.7
Very poor 27 6.8
Functional independence





(when assistance is needed, the older adult has 























(Timed Up & Go test)
0–10 seconds 121 30.7
11–20 seconds 189 48.0
More than 20 seconds 84 21.3
Independent variables
Sample Frailty in the Edmonton Frail Scale (n = 394)
Frailty in the Clinical-Functional 






n % n % n % n %
Weight loss < 0.001 0.001
Yes 59 15.0 31 52.5 28 47.5 21 35.6 38 64.4
No 335 85.0 80 23.9 255 76.1 56 16.7 279 83.3
Presence of caregiver < 0.001 < 0.001
Yes 46 11.7 25 54.3 21 45.7 23 50.0 23 50.0
No 348 88.3 86 24.7 262 75.3 54 15.5 294 84.5
Fall in the past 12 months < 0.001 < 0.001
Yes 123 31.2 54 43.9 69 56.1 39 31.7 84 68.3
No 271 68.8 57 21.0 214 79.0 38 14.0 233 86.0
Hospitalization in the past 12 months < 0.001 < 0.001
Yes 57 14.5 33 57.9 24 42.1 22 38.6 35 61.4
No 337 85.5 78 23.1 259 76.9 55 16.3 282 83.7
Table 1. Demographic, social, economic, and morbidity characterization, health-related care, and frailty-associated factors in community-dwellers 
older adults (bivariate analysis), 2017. (Continuation)
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The EFS found a 28.2% prevalence of frailty, and the CFVI-20 found a 19.5% prevalence of 
high risk of clinical-functional vulnerability (equivalent to frailty in EFS). Table 2 shows the 
frequency distribution of EFS components and Table 3 of CFVI-20 components.
In EFS, 190 older adults (48.2%) presented no frailty, 93 (23.6%) were apparently vulnerable 
to frailty, 74 (18.8%) had mild frailty, 32 (8.1%) moderate frailty, and 5 (1.3%) severe fragility. 
As for the CFVI-20, 207 (52.5%) were robust, or with low risk of frailty, 110 (28.0%) had 
moderate risk of clinical-functional vulnerability, and 77 (19.5%) high risk.
Table 3. Frequency of Clinical-Functional Vulnerability Index-20 components in community-dwellers older adults, 2017.
Clinical-Functional Vulnerability Index-20 components n %
AGE 
60 to 74 years old 226 57.4
75 to 84 years old 128 32.5




other people from the same age group
Excellent/very good/good 226 57.4











Stopped performing minor housework
Yes 80 20.3
No 314 79.7








in the past months
Yes 68 17.3
No 326 82.7





Dismay, sadness, or hopelessness in the past month
Yes 109 27.7
No 285 72.3





Reach, graspingness, and pincer grip
Inability to raise the arm above shoulder level
Yes 35 8.9
No 359 91.1





Unintentional weight loss, 
BMI < 22 kg/m2, calf circumference < 31 cm, or 





to perform some daily activities
Yes 109 27.7
No 285 72.3
Two or more falls in the past year
Yes 110 27.9
No 284 72.1





Vision impairment that may prevent the performance 




Hearing impairment that may prevent the 





Polypathology ≥ 5 chronic diseases
≥ 5 daily medications
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Kappa statistics found a 0.599 agreement index between the instruments (Table 4). Pearson’s 
correlation coefficient between EFS and CFVI-20 was 0.755 (p < 0.001).
Age equal to or greater than 80 years, history of stroke, polypharmacy, negative self-perceived 
health, fall in the past 12 months, and hospitalization in the past 12 months were variables 
that remained statistically associated with frailty in both instruments after multiple 
analysis. Less than four years of education, osteoarticular disease, and weight loss were 
Table 4. Analysis of agreement for frailty classification according to Edmonton Frail Scale and Clinical-Functional 
Vulnerability Index-20 in community-dwellers older adults, 2017.
Edmonton Frail Scale (EFS)
Total
No frailty Frailty
CFVI-20: (n) (%) (n) (%)
No frailty 271 85.5 46 14.5 317
Frailty 12 15.6 65 84.4 77
Kappa = 0.599 (p < 0.001).
Table 5. Frailty-associated factors in community-dwellers older adults according to Edmonton Frail 
Scale and Clinical-Functional Vulnerability Index-20 (multiple analysis), 2017.
Independent variables
Frailty in the Edmonton Frail Scale Frailty in the CFVI-20
PR 95%CI p PR 95%CI p
Age group 0.001 < 0.001
≥ 80 years 1.643 1.239 – 2.178 3.327 2.204 – 5.021
Up to 79 years 1 1
Education level 0.002
Up to 4 years 2.171 1.314 – 3.589
> 4 years 1
Osteoarticular disease 0.016
Yes 1.410 1.065 – 1.865
No 1
Cerebrovascular accident < 0.001 < 0.001
Yes 2.139 1.484 – 3.082 2.546 1.619 – 4.004
No 1 1
Polypharmacy 0.001 0.004
Yes 1.610 1.217 – 2.130 1.657 1.174 – 2.337
No 1 1
Self-perceived health < 0.001 < 0.001
Negative 3.115 2.085 – 4.654 3.294 2.081 – 5.213
Positive 1 1
Weight loss 0.006
Yes 1.542 1.132 – 2.102
No 1
Presence of caregiver 0.020
Yes 1.615 1.078 – 2.419
No 1
Fall in the past 12 months 0.037 0.029
Yes 1.363 1.019 – 1.824 1.503 1.043 – 2.166
No 1 1
Hospitalization in the past 12 months < 0.001 0.005
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associated with frailty only by EFS, and having a caregiver was associated with a higher 
risk of fragility only by CFVI-20 (Table 5).
DISCUSSION
We found a moderate agreement and a strong positive correlation between EFS and 
CFVI-20. The prevalence of frailty in community-dwelling older people was higher in EFS. 
Demographic, social, economic, and morbidity-related factors, as well as health services 
use, influenced frailty in community-dwelling older people, but differences within the 
identification of these variables by the instruments was small.
The similarity and relevance of the main components justify the moderate agreement 
found between the instruments. Both scales assess cognition, functional independence, 
mood, and health conditions (or presence of morbidities). The EFS separately assesses social 
support, medication, nutrition, urinary incontinence, and functional performance; in turn, 
CFVI-20 assesses age, self-perceived health, mobility, and communication12-14.
Our results differ from those reported by a systematic review and the meta-analysis of 
studies conducted in Latin America and the Caribbean26, where the prevalence of frailty 
identified by the EFS in Brazilian community-dwelling older adults was 35.8%, with 
95%CI 30.6–41,226. As for the CFVI-20, although validated in Brazil, few population-based 
studies employed it14.
The different prevalence found in both instruments may be explained by the cutoff point. 
ICVF-20 cut-off point refer fewer older adults for specialized evaluation by screening, 
identifying those with greater needs. Considering the benefit-cost ratio, this process is 
considered positive due to the high cost of broad geriatric assessment. Given that specialized 
care services are not always available, this is an opportunity to optimize resources in 
primary care.
Another possible explanation for the discrepancy between scales prevalence is the differences 
among some of their components: while EFS assesses “social support,” CFVI-20 approaches 
“age” and “communication.” Besides that, similar components are approached differently 
by each instrument. While the EFS assesses “cognition” using the clock drawing test, the 
CFVI-20 does so by evoking words. As the clock drawing test requires number knowledge, 
the low education level among Brazilians older adults may compromise its result. Thus, the 
low performance in this test (which increases the prevalence of frailty) may be related to 
difficulties not necessarily associated to a cognitive deficit13.
EFS assesses “health status” by the number of hospitalizations in the past 12 months; in turn, 
ICVF-20 addresses the number of hospitalizations in the past six months in the component 
“multiple comorbidities.” The instruments also differ regarding “functional independence,” 
or “functional disability”; while EFS approach it by preparing meals/cooking, getting around 
from place to place, using the phone, doing laundry, and taking medicines, CFVI-20 employs 
doing the dishes and bathing.
In the component “medication,” EFS approaches forgetting to take medications, which is 
unregarded by the CFVI-20. In EFS, “functional performance” is evaluated using the timed 
Up & Go Test with a distance of approximately three meters and time stratified by “0 to 
10 seconds,” “11 to 20 seconds,” and “greater than 20 seconds.” CFVI-20, in turn, assesses 
whether the time spent on the 4-meter gait speed test is greater than five seconds.
CFVI-20 also differs from EFS by including the “mobility” component – which assesses the 
ability to raise the arms above the shoulder level and handle or hold small objects, Body 
Mass Index, calf circumference, walking difficulties that may interfere with activities of 
daily living, falls in the past year, and fecal incontinence – and addressing polypathology 
in the “multiple comorbidities” component.
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These factors reveal that the instruments diverse characteristics inf luence the 
prevalence of frailty in older adults. A systematic review27 concluded that frailty 
components and corresponding indicators considerably vary depending on the method 
employed by the instrument. It also reported a lack of consensus regarding which 
elements should be considered to predict frailty and, consequently, increase this 
condition accurate diagnosis27.
Our results found a correlation between advanced age and frailty regardless of the 
instrument used. However, frailty correlation with low education was only identified by 
the EFS. Other studies comparing instruments15,18 also observed this association between 
frailty, advanced age, and lower education level. A longitudinal study conducted in the 
Netherlands identified, besides the association with low education, an association between 
low income and frailty28.
The history of stroke and falls – factors associated with frailty in both instruments, – as well 
as the osteoarticular disease identified by the EFS corroborate results reported by other 
studies4,6,7,15. Osteoarticular disease and stroke sequelae engender functional limitations 
that impair the performance of basic, instrumental, and advanced activities that were 
previously performed without restrictions, increasing the risk of falls.
We also found an association between polypharmacy and frailty in both instruments, a result 
confirmed in this condition consensus3 and also reported by other authors15,28,29. A French 
study found independent and combined effects of polypharmacy and frailty on mortality 
risk factors in older adults28. This vulnerability may be explained by drugs pharmacokinetic 
and pharmacodynamic properties in the aging body, as well as by the potential adverse 
reactions of drug interaction.
The two instruments also showed an association between frailty and negative self-
perceived health – an indicator that incorporates physical, cognitive, and emotional 
components, as well as aspects related to well-being and personal life satisfaction22,23,30. 
Considering that, this measure can predict mortality, functional capacity decline, and 
frailty in older adults.
We also found an association between frailty and weight loss in the EFS. Impaired 
nutritional status is an important sign of frailty in older adults, and dietary intervention is a 
non-pharmacological treatment capable of correcting macro and micronutrient deficiency, 
preventing weight loss that can lead to frailty syndrome7.
Frailty and the presence of a caregiver were only associated in the CFVI-20 and probably 
indicates a reverse causality, that is: the frail older adult needs a caregiver to assist him in 
the activities of daily living7,9,19. Thus, caregivers demand or presence would be markers of 
existing fragility.
Hospitalization was associated with frailty in both instruments – a result also confirmed 
in meta-analysis6. Although chronic diseases are not necessarily accompanied by frailty, 
acute episodes of certain illnesses or exacerbation of chronic conditions may increase the 
risk of adverse events7, leading to frailty in older people and, consequently, to unfavorable 
clinical outcomes, such as hospitalization2,6. Hospitalizations for any reason cause important 
changes in older adults’ daily life.
Comparing instruments capable of identifying frailty in community-dwellers older adults 
may contribute to the search for an applicable instrument, especially at primary healthcare 
and places with few professionals specialized in geriatrics. Despite their peculiarities, both 
scales were akin in identifying associated factors or fragility markers and may be useful to 
health teams in outlining components that most interfere with fragility and in identifying 
older adults who require specialized care. The CFVI-20 seems more useful in a context of 
few resources, for determining a smaller number of patients to be referred for comprehensive 
geriatric assessment.
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Our study has some limitations. The main limitation is the lack of a comprehensive geriatric 
assessment, which would allow other simultaneous analyses of the two instruments. 
However, this procedure was separately performed in the instruments validation. As this 
is a cross-sectional study, we could not establish causal relationships. Moreover, both 
instruments include self-reported components, relying on the memory of the interviewee 
or their caregiver. However, our study carefully evaluated a representative random sample 
of community-dwellers older adults using validated and reliable instruments.
CONCLUSIONS
The EFS and CFVI-20 instruments showed moderate agreement and strong positive 
correlation, as well as similar features for identifying associations. However, the prevalence 
of frailty differed between them. This result stresses the need to standardize the instrument 
for measuring frailty in community-dwellers older adults.
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